Alimera

Alimera Sciences Inc. is a global pharmaceutical company dedicated to preserving vision by protecting the retina. Founded in 2003, the company is headquartered in Alpharetta, Georgia, and has a global presence with offices in Europe and distribution partners worldwide. Their primary focus is on developing and commercializing innovative treatments for retinal diseases, particularly diabetic macular edema (DME), which affects millions of people.

Alimera's core product, ILUVIEN®, is an intravitreal implant that delivers sustained sub-microgram levels of fluocinolone acetonide, providing a therapeutic effect for up to 36 months. The company is committed to research and development, seeking to expand their product portfolio with new and innovative treatments for retinal health. Alimera emphasizes a collaborative approach, working closely with physicians, patients, and partners to achieve their mission of improving vision and lives.

Alimera Sciences is a global pharmaceutical company dedicated to preserving and improving vision by developing and commercializing innovative treatments for retinal diseases. Their mission is to be invaluable to patients, physicians, and partners concerned with retinal health, offering a commitment to providing superior vision care and maintaining better vision for a longer duration.

Alimera promotes a collaborative, patient-centric culture focused on innovation and teamwork. They emphasize finding solutions, setting themselves apart, and being approachable and responsive to their employees, patients, and partners. This dedication to fostering a positive work environment is reflected in their guiding principles: "Find a way, not a way out," "Work together to set ourselves apart," "Be approachable and responsive," and "Don't take our eyes off the retina."

Alimera Sciences emphasizes a culture of collaboration and teamwork, valuing the diverse perspectives and contributions of its employees. This focus on inclusivity is reflected in the company's commitment to protecting the retina and preserving vision, believing that "one of us is never as valuable as ALL of us." While specific details on diversity, equity and inclusion programs aren't explicitly stated, the company's mission and core values suggest a commitment to building a workplace where everyone feels valued and respected.